Literature DB >> 2633113

Expression of MHC class I and class II antigens in colonic carcinomas.

M Norazmi1, A W Hohmann, J M Skinner, J Bradley.   

Abstract

Malignant and non-malignant ('normal') colonic tissues from patients with colonic carcinoma were examined for the expression of MHC class I and class II antigens by immunoenzymatic staining using monoclonal antibodies. The amount of class I antigen as detected by 2 monoclonal antibodies, FMC 16 or W6/32 was clearly diminished in 11 of 14 tumours when compared to the amount present on 'normal' colonic tissue from the same individual. The loss of class I antigen did not correlate with tumour stage or differentiation. The reactivities of FMC 16 and W6/32 with these tissues were not identical, which indicates that the 2 monoclonal antibodies may recognize different epitopes on the HLA class I molecule. Class II antigens were absent from 'normal' colonic epithelium but were present on 20 of 28 tumours, with DR being detected more often than DP, and DQ found only on 4 of 28 tumours. When present, staining for class II antigens was heterogeneous within the tumour, in that all tumour cells did not stain equally. DR and DP antigens were found more often on moderately or poorly differentiated adenocarcinomas and on stage B, C and D tumours in that order of frequency. Thus tumours with a better prognosis were less likely to express DR and DP. The expression of DQ was unrelated to staging or differentiation.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2633113     DOI: 10.3109/00313028909061068

Source DB:  PubMed          Journal:  Pathology        ISSN: 0031-3025            Impact factor:   5.306


  5 in total

Review 1.  Cell surface molecules and their prognostic values in assessing colorectal carcinomas.

Authors:  J Haier; M Nasralla; G L Nicolson
Journal:  Ann Surg       Date:  2000-01       Impact factor: 12.969

Review 2.  Colon cancer and the immune system: the role of tumor invading T cells.

Authors:  Maximilian Waldner; Carl-C Schimanski; Markus-F Neurath
Journal:  World J Gastroenterol       Date:  2006-12-07       Impact factor: 5.742

3.  T cell killing of human colon carcinomas by monoclonal-antibody-targeted superantigens.

Authors:  P A Lando; M Dohlsten; G Hedlund; E Akerblom; T Kalland
Journal:  Cancer Immunol Immunother       Date:  1993       Impact factor: 6.968

4.  MHC class I and II antigen expression and interferon alpha treatment of human midgut carcinoid tumors.

Authors:  C Makridis; C Juhlin; G Akerström; K Oberg; J Rastad
Journal:  World J Surg       Date:  1994 Jul-Aug       Impact factor: 3.352

5.  K-ras mutations and HLA-DR expression in large bowel adenomas.

Authors:  S Norheim Andersen; J Breivik; T Løvig; G I Meling; G Gaudernack; O P Clausen; A Schjölberg; O Fausa; F Langmark; E Lund; T O Rognum
Journal:  Br J Cancer       Date:  1996-07       Impact factor: 7.640

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.